Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement

One third of COVID-19 patients develop significant neurological symptoms, yet SARS-CoV-2 is rarely detected in central nervous system (CNS) tissue, suggesting a potential role for parainfectious processes, including neuroimmune responses. We therefore examined immune parameters in cerebrospinal fluid (CSF) and blood samples from a cohort of patients with COVID-19 and significant neurological complications. We found divergent immunological responses in the CNS compartment, including increased levels of IL-12 and IL-12-associated innate and adaptive immune cell activation. Moreover, we found increased proportions of B cells in the CSF relative to the periphery and evidence of clonal expansion of CSF B cells, suggesting a divergent intrathecal humoral response to SARS-CoV-2. Indeed, all COVID-19 cases examined had anti-SARS-CoV-2 IgG antibodies in the CSF whose target epitopes diverged from serum antibodies. We directly examined whether CSF resident antibodies target self-antigens and found a significant burden of CNS autoimmunity, with the CSF from most patients recognizing neural self-antigens. Finally, we produced a panel of monoclonal antibodies from patients' CSF and show that these target both anti-viral and anti-neural antigens-including one mAb specific for the spike protein that also recognizes neural tissue. This exploratory immune survey reveals evidence of a compartmentalized and self-reactive immune response in the CNS meriting a more systematic evaluation of neurologically impaired COVID-19 patients.

Errataetall:

UpdateIn: Cell Rep Med. 2021 May 18;2(5):100288. - PMID 33969321

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - year:2020

Enthalten in:

bioRxiv : the preprint server for biology - (2020) vom: 09. Dez.

Sprache:

Englisch

Beteiligte Personen:

Song, Eric [VerfasserIn]
Bartley, Christopher M [VerfasserIn]
Chow, Ryan D [VerfasserIn]
Ngo, Thomas T [VerfasserIn]
Jiang, Ruoyi [VerfasserIn]
Zamecnik, Colin R [VerfasserIn]
Dandekar, Ravi [VerfasserIn]
Loudermilk, Rita P [VerfasserIn]
Dai, Yile [VerfasserIn]
Liu, Feimei [VerfasserIn]
Hawes, Isobel A [VerfasserIn]
Alvarenga, Bonny D [VerfasserIn]
Huynh, Trung [VerfasserIn]
McAlpine, Lindsay [VerfasserIn]
Rahman, Nur-Taz [VerfasserIn]
Geng, Bertie [VerfasserIn]
Chiarella, Jennifer [VerfasserIn]
Goldman-Israelow, Benjamin [VerfasserIn]
Vogels, Chantal B F [VerfasserIn]
Grubaugh, Nathan D [VerfasserIn]
Casanovas-Massana, Arnau [VerfasserIn]
Phinney, Brett S [VerfasserIn]
Salemi, Michelle [VerfasserIn]
Alexander, Jessa [VerfasserIn]
Gallego, Juan A [VerfasserIn]
Lencz, Todd [VerfasserIn]
Walsh, Hannah [VerfasserIn]
Lucas, Carolina [VerfasserIn]
Klein, Jon [VerfasserIn]
Mao, Tianyang [VerfasserIn]
Oh, Jieun [VerfasserIn]
Ring, Aaron [VerfasserIn]
Spudich, Serena [VerfasserIn]
Ko, Albert I [VerfasserIn]
Kleinstein, Steven H [VerfasserIn]
DeRisi, Joseph L [VerfasserIn]
Iwasaki, Akiko [VerfasserIn]
Pleasure, Samuel J [VerfasserIn]
Wilson, Michael R [VerfasserIn]
Farhadian, Shelli F [VerfasserIn]

Links:

Volltext

Themen:

Preprint

Anmerkungen:

Date Revised 10.11.2023

published: Electronic

UpdateIn: Cell Rep Med. 2021 May 18;2(5):100288. - PMID 33969321

Citation Status PubMed-not-MEDLINE

doi:

10.1101/2020.09.11.293464

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM315069856